Brief: Tetra Bio Pharma Confirms FDA Meeting Date Regarding Hcc011
06/04/2020 13:31
April 6 (Reuters) - Tetra Bio Pharma Inc TBP.V :
* TETRA BIOPHARMA CONFIRMS TYPE B MEETING DATE WITH FDA
REGARDING
HCC011
Source text for Eikon: ID:nGNX2RDLnd
Further company coverage: TBP.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tetra Bio Pharma
See all newsBrief: Tetra Bio Receives A Second Clarifax From Health Canada Regarding Reduvo Risk Management Plan
Brief: Tetra Bio-Pharma Announces Results Of Artificial Intelligence Study Of ARDS-003 Combined With Favipiravir
Brief: Tetra Bio-Pharma Provides Update On Patent Applications For Novel Therapeutic Ards-003
Brief: Tetra Bio-Pharma Provides Update On Patent Applications For Novel Therapeutic Ards-003
Brief: Tetra And Prepaire Jointly Apply To Barda For Funding